PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis

Molecular and Cellular Biology

Volumn 29, Issue 11, 2009, Pages 3173-3185

  Kleinridders, André ^a,b,c,d,h   Pogoda, Hans Martin ^a   Irlenbusch, Sigrid ^a   Smyth, Neil ^a,e   Koncz, Csaba ^f,g   Hammerschmidt, Matthias ^a   Brüning, Jens C ^a,b,c,d,h  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f MAX PLANCK INSTITUTE FOR PLANT BREEDING RESEARCH   (Germany)

^g INSTITUTE OF BIOCHEMISTRY   (Hungary)

^h Institute for Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; PROTEIN DERIVATIVE; PROTEIN P53; PROTEIN PLRG1; UNCLASSIFIED DRUG; ZEBRAFISH PROTEIN; NUCLEAR PROTEIN; PLRG1 PROTEIN, MOUSE; PLRG1 PROTEIN, ZEBRAFISH; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FIBROBLAST; GENE DELETION; GENOTYPE; HEART MUSCLE CELL; HOMEOSTASIS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TISSUE HOMEOSTASIS; ANIMAL; ANIMAL EMBRYO; ANTIBODY SPECIFICITY; CELL CYCLE; CROSS BREEDING; CYTOLOGY; CYTOPLASM; EMBRYO DEATH; EMBRYO DEVELOPMENT; FEMALE; MALE; METABOLISM; PRENATAL DEVELOPMENT; PROTEIN TRANSPORT; VERTEBRATE; ZEBRA FISH;

DANIO RERIO; MUS; VERTEBRATA;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CROSSES, GENETIC; CYTOPLASM; EMBRYO LOSS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; FIBROBLASTS; HOMEOSTASIS; MALE; MICE; MYOCYTES, CARDIAC; NEURONS; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VERTEBRATES; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 66349114439     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01807-08     Document Type: Article

References (55)

1. Agrelo, R., W. H. Cheng, F. Setien, S. Ropero, J. Espada, M. F. Fraga, M. Herranz, M. F. Paz, M. Sanchez-Cespedes, M. J. Artiga, D. Guerrero, A. Castells, C. von Kobbe, V. A. Bohr, and M. Esteller. 2006. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl. Acad. Sci. USA 103:8822-8827.
2. Ajuh, P., B. Kuster, K. Panov, J. C. Zomerdijk, M. Mann, and A. I. Lamond. 2000. Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J. 19:6569-6581.
3. Ajuh, P., and A. I. Lamond. 2003. Identification of peptide inhibitors of pre-mRNA splicing derived from the essential interaction domains of CDC5L and PLRG1. Nucleic Acids Res. 31:6104-6116. (Pubitemid 37442338)
4. Ajuh, P., J. Sleeman, J. Chusainow, and A. I. Lamond. 2001. A direct interaction between the carboxyl-terminal region of CDC5L and the WD40 domain of PLRG1 is essential for pre-mRNA splicing. J. Biol. Chem. 276: 42370-42381.
5. Albers, M., A. Diment, M. Muraru, C. S. Russell, and J. D. Beggs. 2003. Identification and characterization of Prp45p and Prp46p, essential premRNA splicing factors. RNA 9:138-150. (Pubitemid 36206309)
6. Amsterdam, A., R. M. Nissen, Z. Sun, E. C. Swindell, S. Farrington, and N. Hopkins. 2004. Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. USA 101:12792-12797.
7. Bartek, J., and J. Lukas. 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421-429. (Pubitemid 38340288)
8. Baumgartl, J., S. Baudler, M. Scherner, V. Babaev, L. Makowski, J. Suttles, M. McDuffie, K. Tobe, T. Kadowaki, S. Fazio, C. R. Kahn, G. S. Hotamisligil, W. Krone, M. Linton, and J. C. Bruning. 2006. Myeloid lineage cell-restricted insulin resistance protects apolipoprotein E-deficient mice against atherosclerosis. Cell Metab. 3:247-256.
9. Brown, E. J., and D. Baltimore. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397-402. (Pubitemid 30131885)
10. Brüning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-569. (Pubitemid 128379082)
11. Burns, C. G., R. Ohi, S. Mehta, E. T. O'Toole, M. Winey, T. A. Clark, C. W. Sugnet, M. Ares, Jr., and K. L. Gould. 2002. Removal of a single alphatubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in Saccharomyces cerevisiae. Mol. Cell. Biol. 22:801-815.
12. Cheng, W. H., M. Muftuoglu, and V. A. Bohr. 2007. Werner syndrome protein: functions in the response to DNA damage and replication stress in S-phase. Exp. Gerontol. 42:871-878.
13. Deng, C. X., and S. G. Brodie. 2001. Knockout mouse models and mammary tumorigenesis. Semin. Cancer Biol. 11:387-394.
14. Eggan, K., H. Akutsu, J. Loring, L. Jackson-Grusby, M. Klemm, W. M. Rideout III, R. Yanagimachi, and R. Jaenisch. 2001. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 98:6209-6214.
15. Fernandes-Alnemri, T., G. Litwack, and E. S. Alnemri. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269:30761-30764.
16. Fortschegger, K., B. Wagner, R. Voglauer, H. Katinger, M. Sibilia, and J. Grillari. 2007. Early embryonic lethality of mice lacking the essential protein SNEV. Mol. Cell. Biol. 27:3123-3130.
17. Furutani-Seiki, M., Y. J. Jiang, M. Brand, C. P. Heisenberg, C. Houart, D. Beuchle, F. J. van Eeden, M. Granato, P. Haffter, M. Hammerschmidt, D. A. Kane, R. N. Kelsh, M. C. Mullins, J. Odenthal, and C. Nusslein-Volhard. 1996. Neural degeneration mutants in the zebrafish, Danio rerio. Development 123:229-239. (Pubitemid 27056750)
18. Futami, K., Y. Ishikawa, M. Goto, Y. Furuichi, and M. Sugimoto. 2008. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci. 99:843-848.
19. Gropp, E., M. Shanabrough, E. Borok, A. W. Xu, R. Janoschek, T. Buch, L. Plum, N. Balthasar, B. Hampel, A. Waisman, G. S. Barsh, T. L. Horvath, and J. C. Bruning. 2005. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8:1289-1291.
20. Hammerschmidt, M., F. Pelegri, M. C. Mullins, D. A. Kane, F. J. M. van Eeden, M. Granato, M. Brand, M. Furutani-Seiki, P. Haffter, C.-P. Heisenberg, Y.-J. Jiang, R. N. Kelsh, J. Odenthal, R. M. Warga, and C. Nüsslein- Volhard. 1996. dino and mercedes, two genes regulating dorsal development in the zebrafish embryo. Development 123:95-102.
21. Haupt, S., M. Berger, Z. Goldberg, and Y. Haupt. 2003. Apoptosis-the p53 network. J. Cell Sci. 116:4077-4085.
22. Janoschek, R., L. Plum, L. Koch, H. Munzberg, S. Diano, M. Shanabrough, W. Muller, T. L. Horvath, and J. C. Bruning. 2006. gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 103:10707-10712.
23. Jumaa, H., G. Wei, and P. J. Nielsen. 1999. Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr. Biol. 9:899-902.
24. Kimmel, C. B., W. W. Ballard, S. R. Kimmel, B. Ullmann, and T. F. Schilling. 1995. Stages of embryonic development of the zebrafish. Dev. Dynamics 203:253-310.
25. Kühn, R., and R. M. Torres. 2002. Cre/loxP recombination system and gene targeting. Methods Mol. Biol. 180:175-204.
26. Langheinrich, U., E. Hennen, G. Stott, and G. Vacun. 2002. Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr. Biol. 12:2023-2028.
27. Li, X., and J. L. Manley. 2006. Cotranscriptional processes and their influence on genome stability. Genes Dev. 20:1838-1847. (Pubitemid 44079322)
28. Lombard, D. B., and L. Guarente. 1996. Cloning the gene for Werner syndrome: a disease with many symptoms of premature aging. Trends Genet. 12:283-286. (Pubitemid 26258352)
29. MacFarlane, M., K. Cain, X. M. Sun, E. S. Alnemri, and G. M. Cohen. 1997. Processing/activation of at least four interleukin-1beta converting enzymelike proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol. 137:469-479. (Pubitemid 27181298)
30. Machwe, A., L. Xiao, J. Groden, and D. K. Orren. 2006. The Werner and Bloom syndrome proteins catalyze regression of a model replication fork. Biochemistry 45:13939-13946. (Pubitemid 44846182)
31. Machwe, A., L. Xiao, R. G. Lloyd, E. Bolt, and D. K. Orren. 2007. Replication fork regression in vitro by the Werner syndrome protein (WRN): Holliday junction formation, the effect of leading arm structure and a potential role for WRN exonuclease activity. Nucleic Acids Res. 35:5729-5747. (Pubitemid 47506290)
32. Makarova, O. V., E. M. Makarov, H. Urlaub, C. L. Will, M. Gentzel, M. Wilm, and R. Luhrmann. 2004. A subset of human 35S U5 proteins, including Prp19, function prior to catalytic step 1 of splicing. EMBO J. 23:2381-2391. (Pubitemid 38954845)
33. Merkwirth, C., S. Dargazanli, T. Tatsuta, S. Geimer, B. Lower, F. T. Wunderlich, J. C. von Kleist-Retzow, A. Waisman, B. Westermann, and T. Langer. 2008. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 22:476-488.
34. Murata, K., A. Hatamochi, H. Shinkai, Y. Ishikawa, N. Kawaguchi, and M. Goto. 1999. A case of Werner's syndrome associated with osteosarcoma. J. Dermatol. 26:682-686. (Pubitemid 29510352)
35. Nakagawa, K., Y. Taya, K. Tamai, and M. Yamaizumi. 1999. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell. Biol. 19:2828-2834.
36. Nasevicius, A., and S. C. Ekker. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26:216-220.
37. Németh, K., K. Salchert, P. Putnoky, R. Bhalerao, Z. Koncz-Kalman, B. Stankovic-Stangeland, L. Bako, J. Mathur, L. Okresz, S. Stabel, P. Geigenberger, M. Stitt, G. P. Redei, J. Schell, and C. Koncz. 1998. Pleiotropic control of glucose and hormone responses by PRL1, a nuclear WD protein, in Arabidopsis. Genes Dev. 12:3059-3073. (Pubitemid 28469307)
38. Ohi, M. D., and K. L. Gould. 2002. Characterization of interactions among the Cef1p-Prp19p-associated splicing complex. RNA 8:798-815. (Pubitemid 34620456)
39. Palma, K., Q. Zhao, Y. T. Cheng, D. Bi, J. Monaghan, W. Cheng, Y. Zhang, and X. Li. 2007. Regulation of plant innate immunity by three proteins in a complex conserved across the plant and animal kingdoms. Genes Dev. 21: 1484-1493.
40. Peitz, M., K. Pfannkuche, K. Rajewsky, and F. Edenhofer. 2002. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA 99:4489-4494.
41. Pichierri, P., A. Franchitto, P. Mosesso, and F. Palitti. 2001. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell 12:2412-2421.
42. Plaster, N., C. Sonntag, C. E. Busse, and M. Hammerschmidt. 2006. p53 deficiency rescues apoptosis and differentiation of multiple cell types in zebrafish flathead mutants deficient for zygotic DNA polymerase d1. Cell Death. Diff. 13:223-235.
43. Rao, V. A., C. Conti, J. Guirouilh-Barbat, A. Nakamura, Z. H. Miao, S. L. Davies, B. Sacca, I. D. Hickson, A. Bensimon, and Y. Pommier. 2007. Endogenous gamma-H2AX-ATM-Chk2 checkpoint activation in Bloom's syndrome helicase deficient cells is related to DNA replication arrested forks. Mol. Cancer Res. 5:713-724.
44. Rempe, D., G. Vangeison, J. Hamilton, Y. Li, M. Jepson, and H. J. Federoff. 2006. Synapsin I Cre transgene expression in male mice produces germline recombination in progeny. Genesis 44:44-49. (Pubitemid 43222210)
45. She, Q. B., N. Chen, and Z. Dong. 2000. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275: 20444-20449.
46. Sidorova, J. M., N. Li, A. Folch, and R. J. Monnat, Jr. 2008. The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle 7:796-807.
47. Takai, H., K. Tominaga, N. Motoyama, Y. A. Minamishima, H. Nagahama, T. Tsukiyama, K. Ikeda, K. Nakayama, and M. Nakanishi. 2000. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev. 14:1439-1447. (Pubitemid 30421837)
48. Taylor, W. R., and G. R. Stark. 2001. Regulation of the G2/M transition by p53. Oncogene 20:1803-1815. (Pubitemid 32458690)
49. Tsuzuki, T., Y. Fujii, K. Sakumi, Y. Tominaga, K. Nakao, M. Sekiguchi, A. Matsushiro, Y. Yoshimura, and T. Morita. 1996. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93:6236-6240.
50. Vega, F. M., A. Sevilla, and P. A. Lazo. 2004. p53 stabilization and accumulation induced by human vaccinia-related kinase 1. Mol. Cell. Biol. 24:10366-10380.
51. Wang, J., H. Wilhelmsson, C. Graff, H. Li, A. Oldfors, P. Rustin, J. C. Bruning, C. R. Kahn, D. A. Clayton, G. S. Barsh, P. Thoren, and N. G. Larsson. 1999. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat. Genet. 21:133-137.
52. Williamson, D. J., S. Banik-Maiti, J. DeGregori, and H. E. Ruley. 2000. hnRNP C is required for postimplantation mouse development but is dispensable for cell viability. Mol. Cell. Biol. 20:4094-4105.
53. Zhang, N., R. Kaur, X. Lu, X. Shen, L. Li, and R. J. Legerski. 2005. The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links. J. Biol. Chem. 280:40559-40567.
54. Zhu, J., S. Petersen, L. Tessarollo, and A. Nussenzweig. 2001. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11:105-109.
55. Zhu, Y., M. I. Romero, P. Ghosh, Z. Ye, P. Charnay, E. J. Rushing, J. D. Marth, and L. F. Parada. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15:859-876. (Pubitemid 32295067)